These findings collectively supported the notion that HPAF-II and AsPC-1 cells may have emerged as a result of intrinsic chronic activation of the IFN inflammatory pathways in association with driving dedifferentiation and plasticity from the ductal adenocarcinoma lineage specification. The gene discussed is IFNA1; the disease is invasive ductal breast carcinoma.